Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) Shares outstanding

Alert me on Shares outstanding

Medtronic PLC's shares outstanding at the end of fiscal 2026 was $1.3B, unchanged from fiscal 2025. At the end of the quarter to 31 July 2026 it was $1.3B. Over the past ten years it has ranged from $1.1B (fiscal 2015) to $1.4B (fiscal 2016); the current reading is higher than 17% of that period. Medtronic PLC ranks 3rd of 147 Medical Devices companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2026 $1.3B (0.14%)
FY2025 $1.3B (3.03%)
FY2024 $1.3B (0.20%)
FY2023 $1.3B (1.38%)
FY2022 $1.4B (0.19%)
FY2021 $1.4B 0.21%
FY2020 $1.4B (0.47%)
FY2019 $1.4B (0.78%)
FY2018 $1.4B (1.67%)
FY2017 $1.4B (2.42%)

Quarterly newest first

Period Shares outstanding Change
Jul 2026 $1.3B (0.23%)
Apr 2026 $1.3B (0.11%)
Jan 2026 $1.3B 0.12%
Oct 2025 $1.3B 0.07%
43 more quarters

Against its own ten years

Low $1.1B High $1.4B
Ten-year median $1.4B
Current reading's percentile 17

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on MDT